Washington: Taking up smoking results in epigenetic changes associated with the development of cancer, UK scientists have reported.
Scientists have suspected that smoking causes so-called epigenetic changes, such as methylation, which alter gene expression without causing changes to the actual DNA sequence.
"Until now, however, there has been no direct evidence that smoking induces DNA methylation in humans. Cross-sectional surveys restricted to patients with cancer have revealed that aberrant methylation of several tumor suppressor genes is associated with smoking. But such surveys cannot distinguish those epigenetic changes that are a consequence of the disease process from those which are directly attributable to smoking," said Dr Yuk Ting Ma from the Cancer Research UK Institute of Cancer Studies, Birmingham.
The British team set out to clarify the link between smoking and methylation in a cohort of 2,011 healthy young women aged 15-19 who were originally recruited as part of a study of pre-cancerous changes to cells of the cervix.
"For this particular study we have identified all the women from that cohort who had normal smears and who also tested negative for human papillomavirus throughout follow-up," Dr Ma explained.
"In this subgroup of disease-free women we have then tested the cervical smears of all the women who first started to smoke following study entry for p16 methylation, and compared them to women who were never smokers."
The researchers selected this group of women to ensure there were no potential cofounding factors for the detection of p16 methylation in otherwise healthy young women.
The particular gene the researchers were studying was p16, a so-called tumor suppressor gene. When it is methylated, this gene’s normal tumor-suppressing function is inactivated.
"DNA methylation is a type of epigenetic change that can result in tumor suppressor genes being inactivated. Methylation of p16 has been frequently associated with the development of cancer in many parts of the body," said Dr Ma.
Because the women were all taking part in a study of cervical neoplasia, Dr Ma used cells from cervical smears to test for methylation of p16. Her group found that women who took up smoking during the study were more than three times as likely (odds ratio of 3.67) to acquire p16 methylation.
"Our study showed that compared with never-smokers, women who first started to smoke during follow-up had an increased risk of acquiring methylation of p16. Our choice of study design and our study population allowed us to reveal, for the first time, the relationship between starting to smoke and the subsequent appearance of an epigenetic change," Dr Ma said.
The results were reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
ANI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.